MPA Welcomes Fowler

John Fowler

Boston – Margulies Perruzzi Architects (MPA) recently welcomed John Fowler, AIA, EDAC, LEED AP, to its leadership team as associate principal in the Health+Science studio.

He brings 17 years of experience designing and managing healthcare and laboratory projects of increasing size and complexity, including surgical centers, cancer centers, compounding pharmacies, and master planning for medical campuses.

In addition to leading project teams and managing client relations, Fowler’s new role includes strategic planning and business development to help grow MPA’s Health+Science studio.


“The addition of John Fowler to MPA’s leadership team brings the clients of our Health+Science studio an even greater depth and breadth of technical expertise,” said Marc Margulies, FAIA, LEED AP, senior partner and principal at Margulies Perruzzi Architects. “Leading the Health+Science studio, Jason Costello and John Fowler offer complementary skills and talents in the complex design of healthcare, technology, and scientific projects. They will work together to expand the Health+Science studio and provide clients with technical expertise in new areas.”

“Like MPA, John strives to remain at the forefront of both design and technology, and his experience with LEAN process improvement and leading clinical 3P planning events will help us engage our clients and impact meaningful change in the delivery of healthcare to their patients,” said Jason Costello, AIA, EDAC, associate principal and partner at Margulies Perruzzi Architects. “John’s focus on evidence-based design will promote new healthcare architecture methodologies based upon clinical research that improve patient outcomes and enhance lab efficiency for our clients. We are thrilled to welcome him to the MPA team.”

Prior to joining MPA, Fowler spent 12 years as a project manager and associate principal for a Boston-based healthcare architecture firm, where he designed and managed multiple concurrent healthcare projects ranging from $.5 million to $40 million. His extensive portfolio includes Beth Israel Deaconess Medical Center, Cancer Center, Compounding Pharmacy and Surgical Pavilion in Needham, Mass., Landmark Medical Center (Prime Healthcare) Medical Oncology Center in North Smithfield, Rhode Island, a facility master plan for Beth Israel Deaconess Hospital in Milton, Mass., and a USP 800/247 CMR compliant compounding pharmacy at Signature Healthcare in Brockton, Mass.